Margaret Showel

Assistant Professor

19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Margaret Showel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Cyclophosphamide Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Cytarabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction

Hambley, B. C., Norsworthy, K. J., Jasem, J., Zimmerman, J. W., Shenderov, E., Webster, J., Showel, M., Gondek, L., Dalton, W., Prince, G., Gladstone, D., Streiff, M. B., Pratz, K., Gojo, I., Ghiaur, G., Levis, M. J., Smith, B. D. & Dezern, A., Aug 1 2019, In : Leukemia Research. 83, 106174.

Research output: Contribution to journalLetter

Acute Promyelocytic Leukemia
Fibrinogen
Heparin
Hemorrhage

A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Gojo, I., Beumer, J. H., Pratz, K., McDevitt, M. A., Baer, M. R., Blackford, A. L., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M., Levis, M. J., Dezern, A., Gladstone, D., Ji, J. J., Wang, L., Kinders, R. J., Pouquet, M., Ali-Walbi, I., Rudek-Renaut, M., Poh, W. & 5 others, Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J., Feb 1 2017, In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

Research output: Contribution to journalArticle

temozolomide
Acute Myeloid Leukemia
Methylation
Phosphorylation
Polymers

A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia

Pratz, K., Rudek-Renaut, M., Gojo, I., Litzow, M. R., McDevitt, M. A., Ji, J., Karnitz, L. M., Herman, J. G., Kinders, R. J., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M., Gladstone, D., Levis, M. J., Tsai, H. L., Rosner, G., Chen, A., Kaufmann, S. H. & Karp, J., Feb 15 2017, In : Clinical Cancer Research. 23, 4, p. 899-907 9 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Topotecan
Carboplatin
Leukemia
Neoplasms
Graft vs Host Disease
Cyclophosphamide
Transplantation
Recurrence
Bone Marrow
Graft vs Host Disease
Cyclophosphamide
Disease-Free Survival
Confidence Intervals
Transplants